Nir Modiano, MD
Gastroenterology · Portland, ORNPI 1073790788
Payments from drug & device makers
What this record shows
This record is dominated by education: $23 of the $23 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, Ferring Pharmaceuticals Inc.. That places this record below the midpoint for gastroenterology clinicians in OR, where the typical reported total is $455.
Across 2 payments — averaging $11.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ferring Pharmaceuticals Inc.$23
Across 33 payments — averaging $11,529 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bristol Myers Squibb$372K
- E.r. Squibb & Sons, L.L.C.$8K
What the payments were for
- Education$23100%
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ferring Pharmaceuticals Inc. | 2 | $23 |
How this compares
$23 in reported general payments places this provider in the 5th percentile of 220 gastroenterology providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| StelaraUstekinumab | 25 | $680,428 |
| Skyrizi On-BodyRisankizumab-Rzaa | 29 | $551,220 |
| Humira(Cf) PenAdalimumab | 52 | $458,675 |
| Mesalamine | 26 | $24,546 |
| Budesonide ErBudesonide | 20 | $18,639 |
| Mesalamine DrMesalamine | 12 | $10,501 |
| Mesalamine ErMesalamine | 28 | $8,597 |
| Opium Tincture | 11 | $4,240 |
| Colestipol Hcl | 32 | $4,088 |
| Peg3350-Sod Sul-Nacl-Kcl-Asb-CPeg3350/Sod Sul/Nacl/Kcl/Asb/C | 13 | $1,039 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 40 | $986 |
| Azathioprine | 13 | $723 |
| LoperamideLoperamide Hcl | 13 | $258 |
| Omeprazole | 27 | $234 |
| Ondansetron Hcl | 11 | $233 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Portland
- Donald LumPortland$320K
- Rebecca MatroPortland$154K
- Ian HolmesPortland$102K
- Amy ZhuPortland$72K
- Gregory CotePortland$58K
- Emily JonicaPortland$49K
- Rebecca FauselPortland$29K
- Anil SharmaPortland$14K
- Harry BrayPortland$11K
- Kaveh SharzehiPortland$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.